Abbrea Capital’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,094
Closed -$484K 173
2018
Q3
$484K Buy
5,094
+32
+0.6% +$2.73K 0.14% 117
2018
Q2
$391K Sell
5,062
-55
-1% -$4.13K 0.12% 125
2018
Q1
$353K Buy
5,117
+174
+4% +$13.3K 0.11% 134
2017
Q4
$369K Sell
4,943
-314
-6% -$20.1K 0.13% 125
2017
Q3
$333K Hold
5,257
0.12% 125
2017
Q2
$336K Sell
5,257
-35
-0.7% -$2.2K 0.13% 118
2017
Q1
$349K Buy
5,292
+750
+17% +$51.6K 0.14% 112
2016
Q4
$312K Buy
+4,542
New +$326K 0.15% 115

Other funds holding ESRX

Abbrea Capital's ESRX Position: Q4 2018 in Review

Abbrea Capital sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 5,094 shares — an estimated $484K sold.

Abbrea Capital first reported a position in ESRX in Q4 2016 and held it in 8 quarters. The position peaked at $484K in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Abbrea Capital reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Abbrea Capital sold 5,094 Express Scripts Holding Company shares in Q4 2018, an estimated $484K.
  • Abbrea Capital first reported a position in Express Scripts Holding Company in Q4 2016 and held it in 8 quarters.
  • Abbrea Capital's Express Scripts Holding Company position peaked at $484K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Abbrea Capital's 13F filing for Q4 2018, filed 5 Feb 2019.